---
title: 'Heterogeneity in major depressive disorder: The need for biomarker-based personalized
  treatments'
date: '2023-01-15'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/36642481/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Zkrxt7ktlCbHBXEV3v65xxSnkSWNsJ1A6Fq3gBniKhGfIUslK&fc=20210907212339&ff=20230117201035&v=2.17.9.post6+86293ac
source: metablomics[MeSH Terms]
description: Major Depressive Disorder (MDD) or depression is a pathological mental
  condition affecting millions of people worldwide. Identification of objective biological
  markers of depression can provide for a better diagnostic and intervention criteria;
  ultimately aiding to reduce its socioeconomic health burden. This review provides
  a comprehensive insight into the major biomarker candidates that have been implicated
  in depression neurobiology. The key biomarker categories are covered across all
  ...
---
Major Depressive Disorder (MDD) or depression is a pathological mental condition affecting millions of people worldwide. Identification of objective biological markers of depression can provide for a better diagnostic and intervention criteria; ultimately aiding to reduce its socioeconomic health burden. This review provides a comprehensive insight into the major biomarker candidates that have been implicated in depression neurobiology. The key biomarker categories are covered across all ...